Jacob Glanville
CEO

Centivax develops broad-spectrum vaccines aimed at preventing infectious diseases across different species. Their current focus is on a universal influenza vaccine currently in pre-clinical development for ferrets and pigs. The company seeks to advance global health by creating preventative measures against widespread pathogens.
Raised to date
$10MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.






CEO